Skip to main content

Find Clinical Trials

Home
Conditions
Hypersensitivity, Immediate

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,736 public trials 631 recruiting studies

Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (4 to 15 y) (BY9010/M1-205)

NCT00163410

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Altana Pharma/Nycomed Ahmedabad, India

Altana Pharma/Nycomed Bangalore, India

Altana Pharma/Nycomed Chandigarh, India

Altana Pharma/Nycomed Coimbatore, India

View all 16 locations

View Trial Details

Completed

To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perennial Allergic Rhinitis in Pediatrics (BY9010/M1-405)

NCT00658918

Conditions: Hay Fever, Hypersensitivity, Hypersensitivity, Immediate, +9 more
Locations: Altana/Nycomed Little Rock, Arkansas, United States

View Trial Details

Completed

Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)

NCT00163514

Conditions: Allergic Rhinitis, Hay Fever, Hypersensitivity, +11 more
Locations: Altana Pharma/Nycomed Oxford, Alabama, United States

Altana Pharma/Nycomed Huntington Beach, California, United States

Altana Pharma/Nycomed Mission Viejo, California, United States

Altana Pharma/Nycomed Newport Beach, California, United States

View all 74 locations

View Trial Details

Completed

Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408)

NCT00659048

Conditions: Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations: Altana/Nycomed San Antonio, Texas, United States

View Trial Details

Completed

Clinical and Biological Efficacy of Peanut Oral Immunotherapy

NCT02979600

Conditions: Food Hypersensitivity, Hypersensitivity, Hypersensitivity, Immediate, +4 more
Locations: Not specified

View Trial Details

Completed

A Study in Asthmatics to Determine the Efficacy and Dose Response of Repeat Doses of GW870086X on Forced Expiratory Volume in 1 Second (FEV1)

NCT01245426

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Sofia, Bulgaria

GSK Investigational Site Hamburg, Free and Hanseatic City of Hamburg, Germany

GSK Investigational Site Frankfurt am Main, Hesse, Germany

GSK Investigational Site Hanover, Lower Saxony, Germany

View Trial Details

Completed

Effects of Inhaled Ciclesonide Versus Fluticasone Propionate Versus Placebo on Lower Leg Growth in Prepubertal Children With Mild Persistent Asthma (6 to 12 y) (BY9010/M1-208)

NCT00163371

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Altana Pharma/Nycomed Kolding, Denmark

View Trial Details

Completed

A Study of Ciclesonide Nasal Spray in Patients 18 Years and Older With Seasonal Allergic Rhinitis (BY9010/M1-413)

NCT00384475

Conditions: Hay Fever, Hypersensitivity, Hypersensitivity, Immediate, +8 more
Locations: Altana Pharma/Nycomed Ontario, Mississauga, Canada

View Trial Details

Completed

Effectiveness of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-136)

NCT00163384

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Altana Pharma/Nycomed Busan, South Korea

Altana Pharma/Nycomed Daegu, South Korea

Altana Pharma/Nycomed Daegu, South Korea

Altana Pharma/Nycomed Daejeon, South Korea

View all 19 locations

View Trial Details

Completed

Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)

NCT00163501

Conditions: Allergic Rhinitis, Hay Fever, Hypersensitivity, +11 more
Locations: Altana Pharma/Nycomed Encinitas, California, United States

Altana Pharma/Nycomed Huntington Beach, California, United States

Altana Pharma/Nycomed Long Beach, California, United States

Altana Pharma/Nycomed Los Angeles, California, United States

View all 41 locations

View Trial Details